The method allows analysis of the whole sample with detection of both active and inactive ingredients in these complex matrices. Among the 20 formulations analyzed, 2 were strictly herbal and 4 had a composition corresponding to declared ingredients on the packaging or the WHO further projects that by 2015, approximately 2.3 billion adults will be overweight and more than 700 million will be obese. Overweight and obesity are associated with premature mortality, chronic morbidity, diabetes, heart disease, osteoarthritis and cancer. Given (i) the medical and social impact of being overweight or obese, (ii) the few drugs marketed for these indications, and (iii) the safety concerns of these medications, more and more patients turn to weight-loss natural herbal medicines (HM) or dietary supplements (DS). Indeed, in contrast to conventional pharmaceuticals, these products are regarded by many as being harmless because of their natural origin for HM or of their safe composition (vitamins, minerals, herbs or other botanicals, amino acids, and substances such as enzymes, organ tissues, glandular, and metabolites) for DS.
The WHO's definition indicates that medicines containing plant material combined with chemically defined active substances, including chemically defined, isolated constituents of plants, are not considered to be HM (http://www.who.int/medicines/areas/traditional/ definitions/en/index.html). Moreover, FDA regulations require that a complete list of ingredients and the net contents of the product appear on DS labels (http://www.fda.gov/ food/DietarySupplements/default.htm). Despite these clear definition and regulation and as it is very easy for the consumer to purchase these formulations over the Internet, common problems affecting the safety of these preparations include fraudulent adulteration with synthetic actives used in conventional pharmaceutical drugs which can lead to severe sideeffects.
Reported methods for screening illegal adulterations in HM or DS are mainly HPLC-DAD, GC-MS and LC/MS/MS (Liu et al. 2001; Lau et al. 2003; Bogusz et al. 2006 ; Liang et The analytical methods reported concerning more specifically the adulteration of herbal formulations marketed for weight loss are chromatographic methods coupled with various detectors (Tseng et al. 2000; Jung et al. 2006; Yuen et al. 2007; Zou et al. 2007; Date et al. 2008; Huang et al. 2008; Wang et al. 2008) , capillary electrophoresis (CE) (Cianchino et al. 2008 ) and IR-LSLS (Lu et al. 2007 ). None of these methods is ideal as HM often contain mixture of herbs and other natural products, and the formulas of those products are very complex. Chromatographic methods do not provide global information as they are mainly targeted screening methods and thus sometimes too selective. Moreover, false-positive results might occur with both chromatographic and IR-LSLS methods because it is in fact an analogue of a known active compound with a very close chemical structure which is detected instead of the target compound.
In this study we show an application of 2D Diffusion Ordered SpectroscopY 1 H Nuclear Magnetic Resonance (2D DOSY 1 H NMR) spectroscopy as an untargeted screening method for the detection and unequivocal identification of adulterants in "herbal" slimming products.
The main advantage of NMR is to provide global information as it allows for considering the drug preparation as a whole. Moreover, the method is non-selective and requires no prior knowledge of the structures of the various components present in the mixture, which is a major advantage for screening of adulteration.
Experimental

Samples
Twenty commercial formulations of HM or DS marketed for weight loss were analyzed. Relaxation delay was lengthened to 3 s and 128 scans were recorded for the quantitative analysis of sibutramine, phenolphthalein, synephrine, methylsynephrine, caffeine and vitaberine. The concentrations of adulterant compounds were measured by comparing the expanded areas of their respective NMR signals with that of the internal standard for quantification TSP. The areas were determined by manual integration using TopSpin software. Each data is the mean of at least five integrations. In order to check that the NMR conditions used allowed an accurate quantitation of adulterants, a longer interval between pulses (10 s) was used in some experiments. The same concentration values were obtained, thus demonstrating that a pulse interval of 3 s for a flip angle of 35° is sufficient to record the spectra under conditions of full T 1 relaxation. Sibutramine was assayed from the singlet at 7.47 ppm, phenolphthalein from the two doublets at 7.17 and 6.84 ppm, synephrine from the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The 3D DQF-COSY iDOSY experiment was recorded on formulation 7. In the diffusion dimension, 28 gradient steps were used with 50 ms for the diffusion delay, 1.9 ms for the gradient pulse length and 3 ms for the recovery delay. In the COSY dimension, 8192 × 104 data points were used, corresponding to 0.74 s for acquisition time and 8.6 ms for the other 
MS-MS analysis
An Applied System QTRAP triple-quadrupole mass spectrometer, equipped with a Turbo Ion Spray (TIS) interface and controlled by the Agilent Analyst software (version 1.4), was used for analysis. The mass spectrometer was operated in positive ionization mode.
Nitrogen served both as auxiliary, collision gas and nebulizer gas. The operating conditions for TIS interface were as follows: (i) in MS mode: mass range 100-600 u (1 s), step size 0.1 u; Q1 TIS MS spectra were recorded in profile mode, IS 5000 V, DP 40 V; (ii) in MS-MS mode: precursor mass 280 u; mass range 30-300 u; step size 0.1 u; MS-MS spectra were recorded in profile mode, IS 5000 V, DP 40 V, CE 20 V. All samples were dissolved in MeOH and analyzed after direct introduction.
Preparation of samples for NMR analysis
The tablets were powdered (or capsule emptied) and dissolved in 5 For the quantitative analysis of sibutramine, phenolphthalein, synephrine, methylsynephrine, vitaberine and caffeine found in some formulations, the tablet was powdered (or capsule emptied), and 10% of the powder was dissolved in 10 mL of methanol under magnetic stirring during 15 min and then sonicated for 10 min. An aliquot of 1 mL was evaporated to dryness and the residue dissolved in 1 mL of MeOH-d 4 . TSP was added at a final concentration of 0.2 mM before the NMR analysis. The experiments were done in triplicate.
Results
Conventional 1 H NMR and 2D DOSY 1 H NMR analyses
All formulations were analyzed with 2D DOSY 1 H NMR. 2D DOSY spectra of All the ingredients detected in the herbal drugs studied are reported in Table 2, Table 4 .
Even if sensitivity is not an issue with respect to adulteration, we determined that in the experimental conditions used in this study (1h of recording), 2D DOSY 1 H NMR allows an accurate determination of diffusion coefficients for compounds at a concentration of 50 µM.
The limit of detection corresponds to 10 µM with only CH 2 and CH 3 signals being detected. Other spectra (2C and 2D) are those of the projections from the 3D DOSY-COSY experiment. The main interest of this 3D experiment is to extract the COSY spectrum of each Figure 2D) shows exclusively the signals of sucrose without any signal from phenolphthalein or anomeric protons from α-or β-glucose. These spectra highlight the interest of 3D experiment as virtual separation provided by DOSY acquisition can lead to structural determination by extraction of COSY spectra.
Quantitative analysis
The contents of sibutramine and phenolphthalein in the herbal drugs analyzed were measured by NMR (Table 5) 
Mass spectrometry
The aim of mass spectrometry experiments was to cross-validate NMR data. MS/MS mass spectrometry with ESI ionization was carried out in order to confirm the presence of sibutramine and to investigate the presence of its previously described mono-or di- 
Discussion
To date, identification of synthetic drugs adulterating HM to inhibit appetite and achieve weight loss using NMR and more specifically 2D DOSY 1 H NMR has not been reported. The 
Conclusion
This study presents a new application of 2D DOSY 1 H NMR for the analysis of HM and DS, which are undeniable complex mixtures. Among the twenty formulations marketed for weight loss studied thirteen were adulterated with sibutramine alone or with a combination of sibutramine and phenolphthalein. Adulteration of "natural herbal medicines" with undeclared synthetic drugs is a common and dangerous phenomenon and all the analytical methods that ensure the quality and safety of these products have thus to be developed. In this context, 2D DOSY 1 H NMR spectroscopy is a powerful method for providing a multivariate fingerprint of a very complex mixture especially in situations where the identity of the components is not known beforehand as it permits to consider the drug preparation as a whole. The technique should be now considered as a useful and complementary tool among a standard 2D NMR analytical package. Moreover, its evolution towards 3D DOSY-COSY experiments noticeably increases its interest as structural data are easily obtained. sib, sibutramine; phth, phenolphthalein; sucr, sucrose; gluc, glucose; st, stearate; S, satellite signals from CHD 2 CN; TSP, sodium 2,2,3,3-tetradeutero-3-trimethylsilylpropionate (internal standard); sib* means that the diffusion coefficient of this sibutramine signal is lower due to its superimposition with CHD 2 CN, which affects DOSY processing. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w O n l y 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47 O n l y α/β-glucose 5.14 d (3.5; H1α), 4.53 d (8.0; H1β), 3.84-3.71 m, 3.71-3.60 m, 3.45-3.28 m, 3.15 t (8. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
